GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Azenta Inc (NAS:AZTA) » Definitions » Book to Bill Ratio

Azenta (Azenta) Book to Bill Ratio : 0.00 (As of Sep. 2019)


View and export this data going back to 1995. Start your Free Trial

What is Azenta Book to Bill Ratio?

Book to Bill Ratio is the ratio of orders received to units billed for a specified period.

The historical rank and industry rank for Azenta's Book to Bill Ratio or its related term are showing as below:

AZTA's Book to Bill Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median:
* Ranked among companies with meaningful Book to Bill Ratio only.

Azenta Book to Bill Ratio Historical Data

The historical data trend for Azenta's Book to Bill Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Azenta Book to Bill Ratio Chart

Azenta Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20
Book to Bill Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only

AzentaQuarterly Data
Trend Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Sep18 Sep19
Book to Bill Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only

Competitive Comparison of Azenta's Book to Bill Ratio

For the Medical Instruments & Supplies subindustry, Azenta's Book to Bill Ratio, along with its competitors' market caps and Book to Bill Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Azenta  (NAS:AZTA) Book to Bill Ratio Calculation

Book to Bill Ratio is calculated as

Book to Bill Ratio=Orders Received / Orders Shipped

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Azenta  (NAS:AZTA) Book to Bill Ratio Explanation

The book-to-bill ratio is the ratio of orders received to units shipped and billed for a specified period, generally a month or quarter. It is a widely used metric in the technology industry, specifically in the semiconductor equipment sector. The book-to-bill ratio reveals how quickly a business fulfills the demand for its products.

Investors and analysts closely watch this ratio for an indication of the performance and outlook for individual companies and the technology sector as a whole. A ratio above 1.0 implies more orders were received than filled, indicating strong demand, while a ratio below 1.0 implies weaker demand.

Azenta Book to Bill Ratio Related Terms

Thank you for viewing the detailed overview of Azenta's Book to Bill Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Azenta (Azenta) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Azenta Inc (NAS:AZTA) » Definitions » Book to Bill Ratio
Comparable Companies
NVST ICUI STAA WRBY MMSI LMAT HAE ATRC BLFS ATRI ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD OCSE:COLO B WST TSE:4543 XSWX:STMN
Traded in Other Exchanges
BA3:Germany
Address
200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Website
https://www.azenta.com
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
Executives
Herman Cueto officer: EVP, Chief Financial Officer C/O AZENTA, INC., 200 SUMMIT DRIVE, 6TH FLOOR, BURLINGTON MA 01803
Violetta Hughes officer: VP, Chief Accounting Officer C/O AZENTA, INC., 200 SUMMIT DRIVE, 6TH FLOOR, BURLINGTON MA 01803
David C Gray officer: Chief Strategy & New Business C/O GT SOLAR INTERNATIONAL, INC., 243 DANIEL WEBSTER HIGHWAY, MERRIMACK NH 03054
Joseph R Martin director
Dorothy E Puhy director DANA FARBER CANCER INSTITUTE, 44 BINNEY STREET, RM. D1632, BOSTON MA 02115
Tina Susan Nova director C/O ARENA PHARMACEUTICALS, INC., 6166 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Mitchell Coyne officer: SVP and GM, Life Sciences Proj 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Ginger Zhou officer: SVP and General Manager, Genom 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Matthew Mcmanus officer: EVP & Chief Operating Officer 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Lindon G Robertson officer: EVP & Chief Financial Officer C/O GRAFTECH INTERNATIONAL LTD., 12900 SNOW ROAD, PARMA OH 44130
Kimberly Crowley officer: Chief Human Resources Officer 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Vandana Sriram officer: VP, Finance & Corp. Controller 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Jesus Linda De officer: Chief Commercial Officer, LS 15 ELIZABETH DRIVE, CHEMSFORD MA 01824
David Jarzynka officer: Sr. VP, General Manager 15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Robin Vacha officer: SVP, GM BLS-Products 15 ELIZABETH DRIVE, 15 ELIZABETH DRIVE, CHELMSFORD MA 01824